A phase 2, randomized, double-blind, placebo-controlled study of ubenimex in patients with pulmonary arterial hypertension (WHO Group 1) (LIBERTY)

Administered By

Awarded By

Contributors

Start/End

  • June 1, 2016 - December 31, 2018